Personalized Compounded
GLP-1 Treatments
What you get with Alan
- Personalized medication and dosage adjustments
- Online assessment and provider recommendation
- On-demand access to messaging and ongoing check-ins with licensed medical providers
- If prescribed, medication from 503B pharmacy partners is shipped right to your door
- Lifestyle and nutrition support included to complement your journey
Personalized through Alan
- If clinically appropriate, a provider will prescribe a compounded GLP-1 injection based on your health history and weight loss goals
- Your dosage and how fast you increase your dosage are fully customized to you, and your provider can help make adjustments as needed, anytime
- Medications are prepared by federally regulated 503B compounding pharmacies in the U.S.
Why GLP-1?
- Clinically proven to support weight loss by reducing appetite and improving fullness cues
- Delivered as a once-weekly subcutaneous injection
- Personalized dosing helps maximize effectiveness while minimizing side effects
Potential side effects
- Common side effects may include nausea, fatigue, constipation, or diarrhea—typically mild and temporary
- Your provider may start you on a low dose and increase gradually to help minimize these effects
- Anti-nausea medication may be included in your plan if needed and clinically appropriate
Compounded medications are not reviewed or approved by the FDA for safety, efficacy, or manufacturing quality and are not considered FDA-approved. An online consultation with a licensed provider is required to determine eligibility.
Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded. Wegovy® is FDA-approved for weight loss, while Ozempic® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at a provider’s discretion.
Over 100K doses shipped safely helping thousands reach their goals
Clinically backed treatment for
weight management
Quality results, lab verified
Potency Test
Sterility Test
pH Test
Endotoxicity
Why standards for quality and safety are important
- USP General Chapter <797> Pharmaceutical Compounding—Sterile Preparations: sterility testing requirements.
- USP General Chapter <85> Bacterial Endotoxins Test: endotoxin limits for parenteral drugs.
- Method‑validation guidance outlines acceptable potency recovery of 90‑110 % for non‑regulated drug products.
Experience the Alan Health difference
Personalized doctor-led plans
Get a prescription weight loss plan tailored to your lifestyle and goals, with unique dosages, unlimited ongoing support, and medication adjustments anytime, if appropriate.
Created for convenience
Plans starting as low as $285 a month* and medication shipped directly to your doorstep, if prescribed.
Real people, real results
Average weight loss of 14 lbs in the first 3 months** with compounded GLP-1 medication through Alan Health.
** Compounded semaglutide has not been approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Based on self-reported data from approximately 1,357 Alan Meds customers on a personalized treatment plan including compounded GLP-1 injections, along with a reduced calorie diet and exercise. Customers reported their weight at their initial medical consultation and their first check-in approximately 4 weeks later. Stopping weight loss treatment has been shown to result in weight regain.
How it works
Get started with a 3-minute quiz
Virtual consultation
Personalized treatment plan
Ongoing support and guidance
Frequently Asked Questions
GLP-1 receptor agonists are a class of medications that support appetite regulation and metabolic health. They work by mimicking a hormone your body naturally produces to help reduce hunger, slow digestion, and improve glucose control. Our program uses once-weekly injectable GLP-1 treatment, personalized to your needs.
Many people notice changes in appetite and cravings within the first few weeks. Meaningful weight loss tends to follow after consistent use and dose optimization, usually over the first 2–3 months. Results vary depending on the individual, adherence to the treatment plan, and lifestyle factors. If you have specific questions about your dosage or dosage amount, we encourage you to reach out directly via the Alan Health portal!
- Personalized medication and dosage adjustments with provider-designed titration schedule
- On-demand access to messaging and ongoing check-ins with licensed medical providers
- If prescribed, medication from 503B pharmacy partners is shipped right to your door
- Lifestyle and nutrition support included to complement your journey
We only work with 503B FDA-registered outsourcing facilities that meet the highest standards for sterility, potency, and quality for personalized GLP-1 treatment. These facilities are federally regulated and subject to routine inspections and oversight by the FDA. Medications are batch-tested and produced in controlled environments to meet strict compliance standards.
Your safety is our priority, and we’ve vetted all pharmacy partners to ensure they meet rigorous manufacturing and safety criteria.
No. Our program is self-pay and does not require insurance. This allows us to provide transparent pricing, direct access, and fewer barriers to care.
Once you’ve reached your goal or your provider determines you’re ready to transition, we’ll support you in maintaining your results. This may include reducing your dose, switching to a maintenance plan, or discontinuing medication while continuing healthy lifestyle habits.
Important: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Alan Health Technologies, Inc.™ (doing business as Alan Meds™ and Alan Health™) operates a patient management platform in collaboration with independently owned and operated physician networks, including MDI Medical Group, P.C., and Beluga Health, P.A. Medical services are facilitated through Alan Health™ infrastructure but are provided exclusively by licensed, independent healthcare professionals. Alan Health™ does not itself provide medical or pharmacy services. Payment for services does not guarantee that a prescription will be issued or that medication will be dispensed. Medication appearance, formulation, and packaging may differ from the images displayed on this website.
Prescriptions for any medications require a consultation with a licensed healthcare provider, who will evaluate the patient’s medical condition and determine clinical appropriateness. Additional eligibility criteria may apply. For complete terms and important safety information, please refer to the disclosures provided on our website.
The compounded medications offered through Alan Health™ have not been reviewed or approved by the U.S. Food and Drug Administration (FDA). These products have not been evaluated by the FDA for safety, efficacy, or manufacturing quality and are not considered FDA-approved. The manufacturing processes for these compounded products have also not been reviewed by the FDA.
Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), Zepbound® (tirzepatide), Saxenda® (liraglutide), Victoza® (liraglutide), and generic liraglutide are not compounded products and are not manufactured or supplied by Alan Health Technologies, Inc.™ Ozempic®, Wegovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk™. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company™. These medications are FDA-approved. Alan Health™ is not affiliated with, endorsed by, or sponsored by Novo Nordisk™, Eli Lilly and Company™, or any of their respective affiliates or products.
